TY - JOUR AU - Palumbo, A. AU - Anderson, K. PY - 2011 DA - 2011// TI - Multiple myeloma JO - N Engl J Med VL - 364 UR - https://doi.org/10.1056/NEJMra1011442 DO - 10.1056/NEJMra1011442 ID - Palumbo2011 ER - TY - JOUR AU - Podar, K. AU - Chauhan, D. AU - Anderson, K. C. PY - 2009 DA - 2009// TI - Bone marrow microenvironment and the identification of new targets for myeloma therapy JO - Leukemia VL - 23 UR - https://doi.org/10.1038/leu.2008.259 DO - 10.1038/leu.2008.259 ID - Podar2009 ER - TY - JOUR AU - Manier, S. AU - Sacco, A. AU - Leleu, X. AU - Ghobrial, I. M. AU - Roccaro, A. M. PY - 2012 DA - 2012// TI - Bone marrow microenvironment in multiple myeloma progression JO - J Biomed Biotechnol VL - 2012 UR - https://doi.org/10.1155/2012/157496 DO - 10.1155/2012/157496 ID - Manier2012 ER - TY - JOUR AU - Bahlis, N. P. AU - NJ. PY - 2012 DA - 2012// TI - Targeting of adhesion molecules as a therapeutic strategy in multiple myeloma JO - Curr Cancer Drug Targets VL - 12 UR - https://doi.org/10.2174/156800912802429337 DO - 10.2174/156800912802429337 ID - Bahlis2012 ER - TY - JOUR AU - Hussein, M. A. PY - 2007 DA - 2007// TI - Multiple myeloma: most common end-organ damage and management JO - J Natl Compr Canc Netw VL - 5 UR - https://doi.org/10.6004/jnccn.2007.0017 DO - 10.6004/jnccn.2007.0017 ID - Hussein2007 ER - TY - JOUR AU - Kuehl, W. M. AU - Bergsagel, P. L. PY - 2012 DA - 2012// TI - Molecular pathogenesis of multiple myeloma and its premalignant precursor JO - J Clin Invest VL - 122 UR - https://doi.org/10.1172/JCI61188 DO - 10.1172/JCI61188 ID - Kuehl2012 ER - TY - JOUR AU - Corre, J. AU - Munshi, N. AU - Avet-Loiseau, H. PY - 2015 DA - 2015// TI - Genetics of multiple myeloma: another heterogeneity level? JO - Blood VL - 125 UR - https://doi.org/10.1182/blood-2014-10-567370 DO - 10.1182/blood-2014-10-567370 ID - Corre2015 ER - TY - JOUR AU - Manni, S. AU - Toscani, D. AU - Mandato, E. AU - Brancalion, A. AU - Quotti Tubi, L. AU - Macaccaro, P. PY - 2014 DA - 2014// TI - Bone marrow stromal cell-fueled multiple myeloma growth and osteoclastogenesis are sustained by protein kinase CK2 JO - Leukemia VL - 28 UR - https://doi.org/10.1038/leu.2014.178 DO - 10.1038/leu.2014.178 ID - Manni2014 ER - TY - JOUR AU - Mitsiades, C. S. AU - Mitsiades, N. S. AU - McMullan, C. J. AU - Poulaki, V. AU - Kung, A. L. AU - Davies, F. E. PY - 2006 DA - 2006// TI - Antimyeloma activity of heat shock protein-90 inhibition JO - Blood VL - 107 UR - https://doi.org/10.1182/blood-2005-03-1158 DO - 10.1182/blood-2005-03-1158 ID - Mitsiades2006 ER - TY - JOUR AU - Cea, M. AU - Cagnetta, A. AU - Adamia, S. AU - Acharya, C. AU - Tai, Y. -. T. AU - Fulciniti, M. PY - 2016 DA - 2016// TI - Evidence for a role of the histone deacetylase SIRT6 in DNA damage response of multiple myeloma cells JO - Blood VL - 127 UR - https://doi.org/10.1182/blood-2015-06-649970 DO - 10.1182/blood-2015-06-649970 ID - Cea2016 ER - TY - JOUR AU - Ocio, E. M. AU - San Miguel, J. F. PY - 2010 DA - 2010// TI - The DAC system and associations with multiple myeloma JO - Investig New Drugs VL - 28 UR - https://doi.org/10.1007/s10637-010-9589-x DO - 10.1007/s10637-010-9589-x ID - Ocio2010 ER - TY - JOUR AU - Shaffer, A. L. AU - Emre, N. C. T. AU - Lamy, L. AU - Ngo, V. N. AU - Wright, G. AU - Xiao, W. PY - 2008 DA - 2008// TI - IRF4 addiction in multiple myeloma JO - Nature VL - 454 UR - https://doi.org/10.1038/nature07064 DO - 10.1038/nature07064 ID - Shaffer2008 ER - TY - JOUR AU - Cottini, F. AU - Hideshima, T. AU - Suzuki, R. AU - Tai, Y. -. T. AU - Bianchini, G. AU - Richardson, P. G. PY - 2015 DA - 2015// TI - Synthetic lethal approaches exploiting DNA damage in aggressive myeloma JO - Cancer Discov VL - 5 UR - https://doi.org/10.1158/2159-8290.CD-14-0943 DO - 10.1158/2159-8290.CD-14-0943 ID - Cottini2015 ER - TY - JOUR AU - Hurt, E. M. AU - Thomas, S. B. AU - Peng, B. AU - Farrar, W. L. PY - 2007 DA - 2007// TI - Integrated molecular profiling of SOD2 expression in multiple myeloma JO - Blood VL - 109 UR - https://doi.org/10.1182/blood-2006-07-035162 DO - 10.1182/blood-2006-07-035162 ID - Hurt2007 ER - TY - JOUR AU - Manni, S. AU - Brancalion, A. AU - Tubi, L. Q. AU - Colpo, A. AU - Pavan, L. AU - Cabrelle, A. PY - 2012 DA - 2012// TI - Protein kinase CK2 protects multiple myeloma cells from ER stress-induced apoptosis and from the cytotoxic effect of HSP90 inhibition through regulation of the unfolded protein response JO - Clin Cancer Res VL - 18 UR - https://doi.org/10.1158/1078-0432.CCR-11-1789 DO - 10.1158/1078-0432.CCR-11-1789 ID - Manni2012 ER - TY - JOUR AU - Manni, S. AU - Brancalion, A. AU - Mandato, E. AU - Quotti Tubi, L. AU - Tubi, L. Q. AU - Colpo, A. PY - 2013 DA - 2013// TI - Protein kinase CK2 inhibition down modulates the NF-kappaB and STAT3 survival pathways, enhances the cellular proteotoxic stress and synergistically boosts the cytotoxic effect of bortezomib on multiple myeloma and mantle cell lymphoma cells JO - PLoS One VL - 8 UR - https://doi.org/10.1371/journal.pone.0075280 DO - 10.1371/journal.pone.0075280 ID - Manni2013 ER - TY - JOUR AU - Manni, S. AU - Carrino, M. AU - Manzoni, M. AU - Gianesin, K. AU - Nunes, S. C. AU - Costacurta, M. PY - 2017 DA - 2017// TI - Inactivation of CK1alpha in multiple myeloma empowers drug cytotoxicity by affecting AKT and beta-catenin survival signaling pathways JO - Oncotarget VL - 8 UR - https://doi.org/10.18632/oncotarget.14654 DO - 10.18632/oncotarget.14654 ID - Manni2017 ER - TY - JOUR AU - Knippschild, U. AU - Gocht, A. AU - Wolff, S. AU - Huber, N. AU - Lohler, J. AU - Stoter, M. PY - 2005 DA - 2005// TI - The casein kinase 1 family: participation in multiple cellular processes in eukaryotes JO - Cell Signal VL - 17 UR - https://doi.org/10.1016/j.cellsig.2004.12.011 DO - 10.1016/j.cellsig.2004.12.011 ID - Knippschild2005 ER - TY - JOUR AU - Knippschild, U. AU - Kruger, M. AU - Richter, J. AU - Xu, P. AU - Garcia-Reyes, B. AU - Peifer, C. PY - 2014 DA - 2014// TI - The CK1 family: contribution to cellular stress response and its role in carcinogenesis JO - Front Oncol VL - 4 UR - https://doi.org/10.3389/fonc.2014.00096 DO - 10.3389/fonc.2014.00096 ID - Knippschild2014 ER - TY - JOUR AU - Elyada, E. AU - Pribluda, A. AU - Goldstein, R. E. AU - Morgenstern, Y. AU - Brachya, G. AU - Cojocaru, G. PY - 2011 DA - 2011// TI - CKIalpha ablation highlights a critical role for p53 in invasiveness control JO - Nature VL - 470 UR - https://doi.org/10.1038/nature09673 DO - 10.1038/nature09673 ID - Elyada2011 ER - TY - JOUR AU - Pribluda, A. AU - Elyada, E. AU - Wiener, Z. AU - Hamza, H. AU - Goldstein, R. E. AU - Biton, M. PY - 2013 DA - 2013// TI - A senescence-inflammatory switch from cancer-inhibitory to cancer-promoting mechanism JO - Cancer Cell VL - 24 UR - https://doi.org/10.1016/j.ccr.2013.06.005 DO - 10.1016/j.ccr.2013.06.005 ID - Pribluda2013 ER - TY - JOUR AU - Jaras, M. AU - Miller, P. G. AU - Chu, L. P. AU - Puram, R. V. AU - Fink, E. C. AU - Schneider, R. K. PY - 2014 DA - 2014// TI - Csnk1a1 inhibition has p53-dependent therapeutic efficacy in acute myeloid leukemia JO - J Exp Med VL - 211 UR - https://doi.org/10.1084/jem.20131033 DO - 10.1084/jem.20131033 ID - Jaras2014 ER - TY - JOUR AU - Cheong, J. K. AU - Zhang, F. AU - Chua, P. J. AU - Bay, B. H. AU - Thorburn, A. AU - Virshup, D. M. PY - 2015 DA - 2015// TI - Casein kinase 1alpha-dependent feedback loop controls autophagy in RAS-driven cancers JO - J Clin Invest VL - 125 UR - https://doi.org/10.1172/JCI78018 DO - 10.1172/JCI78018 ID - Cheong2015 ER - TY - JOUR AU - Bidere, N. AU - Ngo, V. N. AU - Lee, J. AU - Collins, C. AU - Zheng, L. AU - Wan, F. PY - 2009 DA - 2009// TI - Casein kinase 1alpha governs antigen-receptor-induced NF-kappaB activation and human lymphoma cell survival JO - Nature VL - 458 UR - https://doi.org/10.1038/nature07613 DO - 10.1038/nature07613 ID - Bidere2009 ER - TY - JOUR AU - Schittek, B. AU - Sinnberg, T. PY - 2014 DA - 2014// TI - Biological functions of casein kinase 1 isoforms and putative roles in tumorigenesis JO - Mol Cancer VL - 13 UR - https://doi.org/10.1186/1476-4598-13-231 DO - 10.1186/1476-4598-13-231 ID - Schittek2014 ER - TY - JOUR AU - Sato, Y. AU - Yoshizato, T. AU - Shiraishi, Y. AU - Maekawa, S. AU - Okuno, Y. AU - Kamura, T. PY - 2013 DA - 2013// TI - Integrated molecular analysis of clear-cell renal cell carcinoma JO - Nat Genet VL - 45 UR - https://doi.org/10.1038/ng.2699 DO - 10.1038/ng.2699 ID - Sato2013 ER - TY - JOUR AU - Okerberg, E. S. AU - Hainley, A. AU - Brown, H. AU - Aban, A. AU - Alemayehu, S. AU - Shih, A. PY - 2016 DA - 2016// TI - Identification of a tumor specific, active-site mutation in casein kinase 1alpha by chemical proteomics JO - PLoS One VL - 11 UR - https://doi.org/10.1371/journal.pone.0152934 DO - 10.1371/journal.pone.0152934 ID - Okerberg2016 ER - TY - JOUR AU - Dulak, A. M. AU - Stojanov, P. AU - Peng, S. AU - Lawrence, M. S. AU - Fox, C. AU - Stewart, C. PY - 2013 DA - 2013// TI - Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity JO - Nat Genet VL - 45 UR - https://doi.org/10.1038/ng.2591 DO - 10.1038/ng.2591 ID - Dulak2013 ER - TY - JOUR AU - Kataoka, K. AU - Nagata, Y. AU - Kitanaka, A. AU - Shiraishi, Y. AU - Shimamura, T. AU - Yasunaga, J. -. I. PY - 2015 DA - 2015// TI - Integrated molecular analysis of adult T cell leukemia/lymphoma JO - Nat Genet VL - 47 UR - https://doi.org/10.1038/ng.3415 DO - 10.1038/ng.3415 ID - Kataoka2015 ER - TY - JOUR AU - Schneider, R. K. AU - Adema, V. AU - Heckl, D. AU - Jaras, M. AU - Mallo, M. AU - Lord, A. M. PY - 2014 DA - 2014// TI - Role of casein kinase 1A1 in the biology and targeted therapy of del(5q) MDS JO - Cancer Cell VL - 26 UR - https://doi.org/10.1016/j.ccr.2014.08.001 DO - 10.1016/j.ccr.2014.08.001 ID - Schneider2014 ER - TY - JOUR AU - Hu, Y. AU - Song, W. AU - Cirstea, D. AU - Lu, D. AU - Munshi, N. C. AU - Anderson, K. C. PY - 2015 DA - 2015// TI - CSNK1alpha1 mediates malignant plasma cell survival JO - Leukemia VL - 29 UR - https://doi.org/10.1038/leu.2014.202 DO - 10.1038/leu.2014.202 ID - Hu2015 ER - TY - JOUR AU - Litchfield, D. W. PY - 2003 DA - 2003// TI - Protein kinase CK2: structure, regulation and role in cellular decisions of life and death JO - Biochem J VL - 369 UR - https://doi.org/10.1042/bj20021469 DO - 10.1042/bj20021469 ID - Litchfield2003 ER - TY - JOUR AU - Gowda, C. AU - Song, C. AU - Kapadia, M. AU - Payne, J. L. AU - Hu, T. AU - Ding, Y. PY - 2017 DA - 2017// TI - Regulation of cellular proliferation in acute lymphoblastic leukemia by Casein Kinase II (CK2) and Ikaros JO - Adv Biol Regul. VL - 63 UR - https://doi.org/10.1016/j.jbior.2016.09.003 DO - 10.1016/j.jbior.2016.09.003 ID - Gowda2017 ER - TY - JOUR AU - Piazza, F. AU - Manni, S. AU - Ruzzene, M. AU - Pinna, L. A. AU - Gurrieri, C. AU - Semenzato, G. PY - 2012 DA - 2012// TI - Protein kinase CK2 in hematologic malignancies: reliance on a pivotal cell survival regulator by oncogenic signaling pathways JO - Leukemia VL - 26 UR - https://doi.org/10.1038/leu.2011.385 DO - 10.1038/leu.2011.385 ID - Piazza2012 ER - TY - JOUR AU - Piazza, F. AU - Manni, S. AU - Semenzato, G. PY - 2013 DA - 2013// TI - Novel players in multiple myeloma pathogenesis: role of protein kinases CK2 and GSK3 JO - Leuk Res VL - 37 UR - https://doi.org/10.1016/j.leukres.2012.10.016 DO - 10.1016/j.leukres.2012.10.016 ID - Piazza2013 ER - TY - JOUR AU - Meggio, F. AU - Pinna, L. A. PY - 2003 DA - 2003// TI - One-thousand-and-one substrates of protein kinase CK2? JO - FASEB J VL - 17 UR - https://doi.org/10.1096/fj.02-0473rev DO - 10.1096/fj.02-0473rev ID - Meggio2003 ER - TY - JOUR AU - Di Maira, G. AU - Salvi, M. AU - Arrigoni, G. AU - Marin, O. AU - Sarno, S. AU - Brustolon, F. PY - 2005 DA - 2005// TI - Protein kinase CK2 phosphorylates and upregulates Akt/PKB JO - Cell Death Differ VL - 12 UR - https://doi.org/10.1038/sj.cdd.4401604 DO - 10.1038/sj.cdd.4401604 ID - Di Maira2005 ER - TY - JOUR AU - Guerra, B. PY - 2006 DA - 2006// TI - Protein kinase CK2 subunits are positive regulators of AKT kinase JO - Int J Oncol VL - 28 ID - Guerra2006 ER - TY - JOUR AU - Channavajhala, P. AU - Seldin, D. C. PY - 2002 DA - 2002// TI - Functional interaction of protein kinase CK2 and c-Myc in lymphomagenesis JO - Oncogene VL - 21 UR - https://doi.org/10.1038/sj.onc.1205640 DO - 10.1038/sj.onc.1205640 ID - Channavajhala2002 ER - TY - JOUR AU - Romieu-Mourez, R. AU - Landesman-Bollag, E. AU - Seldin, D. C. AU - Sonenshein, G. E. PY - 2002 DA - 2002// TI - Protein kinase CK2 promotes aberrant activation of nuclear factor-kappaB, transformed phenotype, and survival of breast cancer cells JO - Cancer Res VL - 62 ID - Romieu-Mourez2002 ER - TY - JOUR AU - Landesman-Bollag, E. AU - Romieu-Mourez, R. AU - Song, D. H. AU - Sonenshein, G. E. AU - Cardiff, R. D. AU - Seldin, D. C. PY - 2001 DA - 2001// TI - Protein kinase CK2 in mammary gland tumorigenesis JO - Oncogene VL - 20 UR - https://doi.org/10.1038/sj.onc.1204411 DO - 10.1038/sj.onc.1204411 ID - Landesman-Bollag2001 ER - TY - JOUR AU - O-charoenrat, P. AU - Rusch, V. AU - Talbot, S. G. AU - Sarkaria, I. AU - Viale, A. AU - Socci, N. PY - 2004 DA - 2004// TI - Casein kinase II alpha subunit and C1-inhibitor are independent predictors of outcome in patients with squamous cell carcinoma of the lung JO - Clin Cancer Res VL - 10 UR - https://doi.org/10.1158/1078-0432.CCR-03-0317 DO - 10.1158/1078-0432.CCR-03-0317 ID - O-charoenrat2004 ER - TY - JOUR AU - Laramas, M. AU - Pasquier, D. AU - Filhol, O. AU - Ringeisen, F. AU - Descotes, J. -. L. AU - Cochet, C. PY - 2007 DA - 2007// TI - Nuclear localization of protein kinase CK2 catalytic subunit (CK2alpha) is associated with poor prognostic factors in human prostate cancer JO - Eur J Cancer VL - 43 UR - https://doi.org/10.1016/j.ejca.2006.11.021 DO - 10.1016/j.ejca.2006.11.021 ID - Laramas2007 ER - TY - JOUR AU - Stalter, G. AU - Siemer, S. AU - Becht, E. AU - Ziegler, M. AU - Remberger, K. AU - Issinger, O. G. PY - 1994 DA - 1994// TI - Asymmetric expression of protein kinase CK2 subunits in human kidney tumors JO - Biochem Biophys Res Commun VL - 202 UR - https://doi.org/10.1006/bbrc.1994.1904 DO - 10.1006/bbrc.1994.1904 ID - Stalter1994 ER - TY - JOUR AU - Zhang, X. AU - Yang, X. AU - Yang, C. AU - Li, P. AU - Yuan, W. AU - Deng, X. PY - 2016 DA - 2016// TI - Targeting protein kinase CK2 suppresses bladder cancer cell survival via the glucose metabolic pathway JO - Oncotarget VL - 7 ID - Zhang2016 ER - TY - JOUR AU - Zhou, B. AU - Ritt, D. A. AU - Morrison, D. K. AU - Der, C. J. AU - Cox, A. D. PY - 2016 DA - 2016// TI - Protein kinase CK2alpha maintains extracellular signal-regulated kinase (ERK) activity in a CK2alpha kinase-independent manner to promote resistance to inhibitors of RAF and MEK but not ERK in BRAF mutant melanoma JO - J Biol Chem VL - 291 UR - https://doi.org/10.1074/jbc.M115.712885 DO - 10.1074/jbc.M115.712885 ID - Zhou2016 ER - TY - JOUR AU - Mandato, E. AU - Manni, S. AU - Zaffino, F. AU - Semenzato, G. AU - Piazza, F. PY - 2016 DA - 2016// TI - Targeting CK2-driven non-oncogene addiction in B-cell tumors JO - Oncogene VL - 35 UR - https://doi.org/10.1038/onc.2016.86 DO - 10.1038/onc.2016.86 ID - Mandato2016 ER - TY - JOUR AU - Ruzzene, M. AU - Pinna, L. A. PY - 1804 DA - 1804// TI - Addiction to protein kinase CK2: a common denominator of diverse cancer cells? JO - Biochim Biophys Acta VL - 2010 ID - Ruzzene1804 ER - TY - JOUR AU - Broseus, J. AU - Chen, G. AU - Hergalant, S. AU - Ramstein, G. AU - Mounier, N. AU - Gueant, J. -. L. PY - 2016 DA - 2016// TI - Relapsed diffuse large B-cell lymphoma present different genomic profiles between early and late relapses JO - Oncotarget VL - 7 UR - https://doi.org/10.18632/oncotarget.9793 DO - 10.18632/oncotarget.9793 ID - Broseus2016 ER - TY - JOUR AU - Whitmarsh, A. J. PY - 2011 DA - 2011// TI - Casein kinase 2 sends extracellular signal-regulated kinase nuclear JO - Mol Cell Biol VL - 31 UR - https://doi.org/10.1128/MCB.05916-11 DO - 10.1128/MCB.05916-11 ID - Whitmarsh2011 ER - TY - JOUR AU - Ponce, D. P. AU - Yefi, R. AU - Cabello, P. AU - Maturana, J. L. AU - Niechi, I. AU - Silva, E. PY - 2011 DA - 2011// TI - CK2 functionally interacts with AKT/PKB to promote the beta-catenin-dependent expression of survivin and enhance cell survival JO - Mol Cell Biochem VL - 356 UR - https://doi.org/10.1007/s11010-011-0965-4 DO - 10.1007/s11010-011-0965-4 ID - Ponce2011 ER - TY - JOUR AU - Park, J. H. AU - Kim, J. J. AU - Bae, Y. -. S. PY - 2013 DA - 2013// TI - Involvement of PI3K-AKT-mTOR pathway in protein kinase CKII inhibition-mediated senescence in human colon cancer cells JO - Biochem Biophys Res Commun VL - 433 UR - https://doi.org/10.1016/j.bbrc.2013.02.108 DO - 10.1016/j.bbrc.2013.02.108 ID - Park2013 ER - TY - STD TI - Ruzzene M, Bertacchini J, Toker A, Marmiroli S. Cross-talk between the CK2 and AKT signaling pathways in cancer. Adv Biol Regul. 2017;64:1–8. ID - ref53 ER - TY - JOUR AU - Quotti Tubi, L. AU - Canovas Nunes, S. AU - Brancalion, A. AU - Doriguzzi Breatta, E. AU - Manni, S. AU - Mandato, E. PY - 2017 DA - 2017// TI - Protein kinase CK2 regulates AKT, NF-kappaB and STAT3 activation, stem cell viability and proliferation in acute myeloid leukemia JO - Leukemia VL - 31 UR - https://doi.org/10.1038/leu.2016.209 DO - 10.1038/leu.2016.209 ID - Quotti Tubi2017 ER - TY - JOUR AU - Silva, A. AU - Jotta, P. Y. AU - Silveira, A. B. AU - Ribeiro, D. AU - Brandalise, S. R. AU - Yunes, J. A. PY - 2010 DA - 2010// TI - Regulation of PTEN by CK2 and Notch1 in primary T-cell acute lymphoblastic leukemia: rationale for combined use of CK2- and gamma-secretase inhibitors JO - Haematologica VL - 95 UR - https://doi.org/10.3324/haematol.2009.011999 DO - 10.3324/haematol.2009.011999 ID - Silva2010 ER - TY - JOUR AU - Romieu-Mourez, R. AU - Landesman-Bollag, E. AU - Seldin, D. C. AU - Traish, A. M. AU - Mercurio, F. AU - Sonenshein, G. E. PY - 2001 DA - 2001// TI - Roles of IKK kinases and protein kinase CK2 in activation of nuclear factor-kappaB in breast cancer JO - Cancer Res VL - 61 ID - Romieu-Mourez2001 ER - TY - JOUR AU - Ponce, D. P. AU - Maturana, J. L. AU - Cabello, P. AU - Yefi, R. AU - Niechi, I. AU - Silva, E. PY - 2011 DA - 2011// TI - Phosphorylation of AKT/PKB by CK2 is necessary for the AKT-dependent up-regulation of beta-catenin transcriptional activity JO - J Cell Physiol VL - 226 UR - https://doi.org/10.1002/jcp.22527 DO - 10.1002/jcp.22527 ID - Ponce2011 ER - TY - JOUR AU - Zhang, S. AU - Yang, Y. -. L. AU - Wang, Y. AU - You, B. AU - Dai, Y. AU - Chan, G. PY - 2014 DA - 2014// TI - CK2alpha, over-expressed in human malignant pleural mesothelioma, regulates the Hedgehog signaling pathway in mesothelioma cells JO - J Exp Clin Cancer Res VL - 33 ID - Zhang2014 ER - TY - JOUR AU - Wang, D. AU - Westerheide, S. D. AU - Hanson, J. L. AU - Baldwin, A. S. PY - 2000 DA - 2000// TI - Tumor necrosis factor alpha-induced phosphorylation of RelA/p65 on Ser529 is controlled by casein kinase II JO - J Biol Chem VL - 275 UR - https://doi.org/10.1074/jbc.M001358200 DO - 10.1074/jbc.M001358200 ID - Wang2000 ER - TY - JOUR AU - Seldin, D. C. AU - Landesman-Bollag, E. AU - Farago, M. AU - Currier, N. AU - Lou, D. AU - Dominguez, I. PY - 2005 DA - 2005// TI - CK2 as a positive regulator of Wnt signalling and tumourigenesis JO - Mol Cell Biochem VL - 274 UR - https://doi.org/10.1007/s11010-005-3078-0 DO - 10.1007/s11010-005-3078-0 ID - Seldin2005 ER - TY - JOUR AU - Gao, Y. AU - Wang, H. Y. PY - 2006 DA - 2006// TI - Casein kinase 2 is activated and essential for Wnt/beta-catenin signaling JO - J Biol Chem VL - 281 UR - https://doi.org/10.1074/jbc.M601112200 DO - 10.1074/jbc.M601112200 ID - Gao2006 ER - TY - JOUR AU - Zhang, S. AU - Wang, Y. AU - Mao, J. -. H. AU - Hsieh, D. AU - Kim, I. -. J. AU - Hu, L. -. M. PY - 2012 DA - 2012// TI - Inhibition of CK2alpha down-regulates Hedgehog/Gli signaling leading to a reduction of a stem-like side population in human lung cancer cells JO - PLoS One VL - 7 UR - https://doi.org/10.1371/journal.pone.0038996 DO - 10.1371/journal.pone.0038996 ID - Zhang2012 ER - TY - JOUR AU - Siddiqui-Jain, A. AU - Bliesath, J. AU - Macalino, D. AU - Omori, M. AU - Huser, N. AU - Streiner, N. PY - 2012 DA - 2012// TI - CK2 inhibitor CX-4945 suppresses DNA repair response triggered by DNA-targeted anticancer drugs and augments efficacy: mechanistic rationale for drug combination therapy JO - Mol Cancer Ther VL - 11 UR - https://doi.org/10.1158/1535-7163.MCT-11-0613 DO - 10.1158/1535-7163.MCT-11-0613 ID - Siddiqui-Jain2012 ER - TY - JOUR AU - Olsen, B. B. AU - Wang, S. -. Y. AU - Svenstrup, T. H. AU - BPC, C. AU - Guerra, B. PY - 2012 DA - 2012// TI - Protein kinase CK2 localizes to sites of DNA double-strand break regulating the cellular response to DNA damage JO - BMC Mol Biol VL - 13 UR - https://doi.org/10.1186/1471-2199-13-7 DO - 10.1186/1471-2199-13-7 ID - Olsen2012 ER - TY - JOUR AU - Olsen, B. B. AU - Svenstrup, T. H. AU - Guerra, B. PY - 2012 DA - 2012// TI - Downregulation of protein kinase CK2 induces autophagic cell death through modulation of the mTOR and MAPK signaling pathways in human glioblastoma cells JO - Int J Oncol VL - 41 UR - https://doi.org/10.3892/ijo.2012.1635 DO - 10.3892/ijo.2012.1635 ID - Olsen2012 ER - TY - JOUR AU - Buontempo, F. AU - Orsini, E. AU - Lonetti, A. AU - Cappellini, A. AU - Chiarini, F. AU - Evangelisti, C. PY - 2016 DA - 2016// TI - Synergistic cytotoxic effects of bortezomib and CK2 inhibitor CX-4945 in acute lymphoblastic leukemia: turning off the prosurvival ER chaperone BIP/Grp78 and turning on the pro-apoptotic NF-kappaB JO - Oncotarget VL - 7 UR - https://doi.org/10.18632/oncotarget.6361 DO - 10.18632/oncotarget.6361 ID - Buontempo2016 ER - TY - JOUR AU - Turowec, J. P. AU - Duncan, J. S. AU - Gloor, G. B. AU - Litchfield, D. W. PY - 2011 DA - 2011// TI - Regulation of caspase pathways by protein kinase CK2: identification of proteins with overlapping CK2 and caspase consensus motifs JO - Mol Cell Biochem VL - 356 UR - https://doi.org/10.1007/s11010-011-0972-5 DO - 10.1007/s11010-011-0972-5 ID - Turowec2011 ER - TY - JOUR AU - Turowec, J. P. AU - Vilk, G. AU - Gabriel, M. AU - Litchfield, D. W. PY - 2013 DA - 2013// TI - Characterizing the convergence of protein kinase CK2 and caspase-3 reveals isoform-specific phosphorylation of caspase-3 by CK2alpha': implications for pathological roles of CK2 in promoting cancer cell survival JO - Oncotarget VL - 4 UR - https://doi.org/10.18632/oncotarget.948 DO - 10.18632/oncotarget.948 ID - Turowec2013 ER - TY - STD TI - Parrish AB, Freel CD, Kornbluth S. Cellular mechanisms controlling caspase activation and function. Cold Spring Harb Perspect Biol. 2013;5:a008672. ID - ref69 ER - TY - JOUR AU - Kronke, J. AU - Fink, E. C. AU - Hollenbach, P. W. AU - MacBeth, K. J. AU - Hurst, S. N. AU - Udeshi, N. D. PY - 2015 DA - 2015// TI - Lenalidomide induces ubiquitination and degradation of CK1alpha in del(5q) MDS JO - Nature VL - 523 UR - https://doi.org/10.1038/nature14610 DO - 10.1038/nature14610 ID - Kronke2015 ER - TY - JOUR AU - Piazza, F. A. AU - Ruzzene, M. AU - Gurrieri, C. AU - Montini, B. AU - Bonanni, L. AU - Chioetto, G. PY - 2006 DA - 2006// TI - Multiple myeloma cell survival relies on high activity of protein kinase CK2 JO - Blood VL - 108 UR - https://doi.org/10.1182/blood-2005-11-013672 DO - 10.1182/blood-2005-11-013672 ID - Piazza2006 ER - TY - JOUR AU - Nishida, M. Y. AU - E. PY - 2004 DA - 2004// TI - CK2 controls multiple protein kinases by phosphorylating a kinase-targeting molecular chaperone, Cdc37 JO - Mol Cell Biol VL - 24 UR - https://doi.org/10.1128/MCB.24.24.10611-10620.2004 DO - 10.1128/MCB.24.24.10611-10620.2004 ID - Nishida2004 ER - TY - JOUR AU - Miyata, Y. PY - 2009 DA - 2009// TI - Protein kinase CK2 in health and disease: CK2: the kinase controlling the Hsp90 chaperone machinery JO - Cell Mol Life Sci VL - 66 UR - https://doi.org/10.1007/s00018-009-9152-0 DO - 10.1007/s00018-009-9152-0 ID - Miyata2009 ER - TY - JOUR AU - Hessenauer, A. AU - Schneider, C. C. AU - Gotz, C. AU - Montenarh, M. PY - 2011 DA - 2011// TI - CK2 inhibition induces apoptosis via the ER stress response JO - Cell Signal VL - 23 UR - https://doi.org/10.1016/j.cellsig.2010.08.014 DO - 10.1016/j.cellsig.2010.08.014 ID - Hessenauer2011 ER - TY - JOUR AU - Muller, P. AU - Ruckova, E. AU - Halada, P. AU - Coates, P. J. AU - Hrstka, R. AU - Lane, D. P. PY - 2013 DA - 2013// TI - C-terminal phosphorylation of Hsp70 and Hsp90 regulates alternate binding to co-chaperones CHIP and HOP to determine cellular protein folding/degradation balances JO - Oncogene VL - 32 UR - https://doi.org/10.1038/onc.2012.314 DO - 10.1038/onc.2012.314 ID - Muller2013 ER - TY - JOUR AU - Fernandez-Saiz, V. AU - Targosz, B. S. AU - Lemeer, S. AU - Eichner, R. AU - Langer, C. AU - Bullinger, L. PY - 2013 DA - 2013// TI - SCFFbxo9 and CK2 direct the cellular response to growth factor withdrawal via Tel2/Tti1 degradation and promote survival in multiple myeloma JO - Nat Cell Biol VL - 15 UR - https://doi.org/10.1038/ncb2651 DO - 10.1038/ncb2651 ID - Fernandez-Saiz2013 ER - TY - STD TI - Costa F, Vescovini R, Bolzoni M, Marchica V, Storti P, Toscani D, et al. Lenalidomide increases human dendritic cell maturation in multiple myeloma patients targeting monocyte differentiation and modulating mesenchymal stromal cell inhibitory properties: Oncotarget; 2017. doi:10.18632/oncotarget.18085. ID - ref77 ER - TY - JOUR AU - An, X. AU - Tiwari, A. K. AU - Sun, Y. AU - Ding, P. -. R. AU - Ashby, C. R. AU - Chen, Z. -. S. PY - 2010 DA - 2010// TI - BCR-ABL tyrosine kinase inhibitors in the treatment of Philadelphia chromosome positive chronic myeloid leukemia: a review JO - Leuk Res VL - 34 UR - https://doi.org/10.1016/j.leukres.2010.04.016 DO - 10.1016/j.leukres.2010.04.016 ID - An2010 ER - TY - STD TI - Jerkeman M, Hallek M, Dreyling M, Thieblemont C, Kimby E, Staudt L. Targeting of B-cell receptor signalling in B-cell malignancies. J Intern Med. 2017. doi:10.1111/joim.12600. ID - ref79 ER - TY - JOUR AU - Young, R. M. AU - Shaffer, A. L. AU - Phelan, J. D. AU - Staudt, L. M. PY - 2015 DA - 2015// TI - B-cell receptor signaling in diffuse large B-cell lymphoma JO - Semin Hematol VL - 52 UR - https://doi.org/10.1053/j.seminhematol.2015.01.008 DO - 10.1053/j.seminhematol.2015.01.008 ID - Young2015 ER - TY - JOUR AU - Pizzi, M. AU - Piazza, F. AU - Agostinelli, C. AU - Fuligni, F. AU - Benvenuti, P. AU - Mandato, E. PY - 2015 DA - 2015// TI - Protein kinase CK2 is widely expressed in follicular, Burkitt and diffuse large B-cell lymphomas and propels malignant B-cell growth JO - Oncotarget VL - 6 UR - https://doi.org/10.18632/oncotarget.3446 DO - 10.18632/oncotarget.3446 ID - Pizzi2015 ER - TY - JOUR AU - Quotti Tubi, L. AU - Gurrieri, C. AU - Brancalion, A. AU - Bonaldi, L. AU - Bertorelle, R. AU - Manni, S. PY - 2013 DA - 2013// TI - Inhibition of protein kinase CK2 with the clinical-grade small ATP-competitive compound CX-4945 or by RNA interference unveils its role in acute myeloid leukemia cell survival, p53-dependent apoptosis and daunorubicin-induced cytotoxicity JO - J Hematol Oncol VL - 6 UR - https://doi.org/10.1186/1756-8722-6-78 DO - 10.1186/1756-8722-6-78 ID - Quotti Tubi2013 ER - TY - JOUR AU - Prins, R. C. AU - Burke, R. T. AU - Tyner, J. W. AU - Druker, B. J. AU - Loriaux, M. M. AU - Spurgeon, S. E. PY - 2013 DA - 2013// TI - CX-4945, a selective inhibitor of casein kinase-2 (CK2), exhibits anti-tumor activity in hematologic malignancies including enhanced activity in chronic lymphocytic leukemia when combined with fludarabine and inhibitors of the B-cell receptor pathway JO - Leukemia VL - 27 UR - https://doi.org/10.1038/leu.2013.228 DO - 10.1038/leu.2013.228 ID - Prins2013 ER - TY - JOUR AU - Martins, L. R. AU - Perera, Y. AU - Lucio, P. AU - Silva, M. G. AU - Perea, S. E. AU - Barata, J. T. PY - 2014 DA - 2014// TI - Targeting chronic lymphocytic leukemia using CIGB-300, a clinical-stage CK2-specific cell-permeable peptide inhibitor JO - Oncotarget VL - 5 UR - https://doi.org/10.18632/oncotarget.1513 DO - 10.18632/oncotarget.1513 ID - Martins2014 ER - TY - JOUR AU - Chon, H. J. AU - Bae, K. J. AU - Lee, Y. AU - Kim, J. PY - 2015 DA - 2015// TI - The casein kinase 2 inhibitor, CX-4945, as an anti-cancer drug in treatment of human hematological malignancies JO - Front Pharmacol VL - 6 UR - https://doi.org/10.3389/fphar.2015.00070 DO - 10.3389/fphar.2015.00070 ID - Chon2015 ER -